Inflammatory rheumatic diseases
Conditions
Interventions
Group 1: Arm 1 (order: comic ? information sheet)
After randomisation, participants first read the comic-based information sheet on biologics (reading phase 1) and then complete an evaluation form. Th
Sponsors
Abteilung Rheumatologie, Klinikum Nürnberg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Confirmed inflammatory rheumatic diagnosis • Current bDMARD therapy • Sufficient knowledge of German • Capacity to give consent
Exclusion criteria
Exclusion criteria: Severe, irreversible visual impairment/reading impairment Acute rheumatic flare-up (medical assessment)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient satisfaction with the respective information material is the primary endpoint of the study. This parameter is assessed immediately after reading the comic or leaflet. The assessment is carried out using an evaluation questionnaire developed specifically for this study, in which satisfaction is rated on a five-point Likert scale (1 = strongly disagree to 5 = strongly agree). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints include preference for one of the two information materials (comic versus leaflet), perceived comprehensibility, usefulness/relevance, trustworthiness and aesthetics/reading enjoyment, as well as knowledge gain, reading time, willingness to recommend and decision certainty. The materials are evaluated immediately after reading using study-specific questionnaires with five-point Likert scales. Knowledge gain is measured using a multiple-choice knowledge quiz after each reading phase, and reading time is measured in seconds. Preference, willingness to recommend (Net Promoter Score, 0–10) and decision certainty are assessed once at the end of the study participation. | — |
Countries
Germany
Contacts
Public ContactAxel Hueber
Abteilung Rheumatologie, Klinikum Nürnberg
Outcome results
None listed